What is CJC-1295?
Stimulates the pituitary gland to release more of the body's own growth hormone. The “DAC” version binds to albumin and therefore acts for days.
How well studied is CJC-1295?
Early human studies (2006) showed a clear, sustained rise in GH and IGF-1. Clinical development was discontinued afterwards.
What side effects and risks does CJC-1295 have?
Water retention, tingling, flushing, possible effects on blood sugar. Persistently elevated IGF-1 is a debated risk factor. No long-term data.
Is CJC-1295 approved in Germany?
In short: no. Not approved. Banned in sport (WADA S2).
Sources
Note: We deliberately do not list any doses here. For approved medicines, your doctor sets the dose; for unapproved substances there is no reliable information.